# Indokem (NSE: INDOKEM) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/INDOKEM · Pivot · prices to 22 Oct 2026

Indokem (NSE: INDOKEM) closed at ₹673.85 on 22 Oct 2026, down 0.92% on the day. With a market capitalisation of ₹1,879 Cr, it ranks 1169th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Chemicals sector; its industry is Specialty Chemicals.

Its return on equity was 2.9% in FY26. Its 52-week range is ₹555.00 (16 Sep 2026) to ₹770.95 (19 Oct 2026); the last close is 12.6% below the high. In Q1 FY27, the quarter ended 30 Jun 2026, revenue was ₹47 Cr (+12.2% year on year) and net profit ₹1 Cr (+52.9%), on a consolidated basis. Promoters held 68.67% of the company as of 30 Jun 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Last close | ₹673.85 |
| Market cap | ₹1,879 Cr |
| ROE | 2.9% (FY26) |
| ROCE | 5.6% (FY26) |
| Debt to equity | 0.42 |
| 52-week high | ₹770.95 (19 Oct 2026) |
| 52-week low | ₹555.00 (16 Sep 2026) |

## Quarterly results (₹ crore, consolidated)

| Quarter | Revenue | Revenue YoY | Net profit | Net profit YoY | EPS (₹) |
| --- | --- | --- | --- | --- | --- |
| Q1 FY27 | ₹47 Cr | +12.2% | ₹1 Cr | +52.9% | ₹0.38 |
| Q4 FY26 | ₹46 Cr | −16.4% | ₹0 Cr | −91.1% | ₹0.13 |
| Q3 FY26 | ₹42 Cr | −3.2% | ₹0 Cr | −45.2% | ₹0.15 |
| Q2 FY26 | ₹40 Cr | −6.9% | ₹0 Cr | — | ₹0.15 |
| Q1 FY26 | ₹42 Cr | +12.4% | ₹1 Cr | — | ₹0.25 |
| Q4 FY25 | ₹54 Cr | +35.9% | ₹4 Cr | — | ₹1.36 |
| Q3 FY25 | ₹43 Cr | +7.8% | ₹1 Cr | — | ₹0.26 |
| Q2 FY25 | ₹43 Cr | — | −₹0 Cr | — | ₹0.00 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹178 Cr | ₹3 Cr |
| FY24 | ₹165 Cr | −₹6 Cr |
| FY23 | ₹161 Cr | −₹1 Cr |
| FY11 | ₹28 Cr | −₹9 Cr |
| FY10 | ₹52 Cr | −₹10 Cr |
| FY09 | ₹69 Cr | −₹3 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 68.67%
- Domestic institutions: 0.19%
- Non-institutions: 31.14%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [India Glycols](https://app.pivotnow.in/stock/INDIAGLYCO) | ₹305.55 | ₹2,048 Cr | 6.6 | — |
| [Oriental Aromatics](https://app.pivotnow.in/stock/OAL) | ₹605.80 | ₹2,039 Cr | — | — |
| [Bodal Chemicals](https://app.pivotnow.in/stock/BODALCHEM) | ₹150.00 | ₹1,889 Cr | 39.5 | — |
| [S H Kelkar and Company](https://app.pivotnow.in/stock/SHK) | ₹131.67 | ₹1,823 Cr | 26.3 | — |
| [IG Petrochemicals](https://app.pivotnow.in/stock/IGPL) | ₹555.00 | ₹1,709 Cr | — | — |
| [GOCL Corporation](https://app.pivotnow.in/stock/GOCLCORP) | ₹343.10 | ₹1,701 Cr | 6.1 | — |

## Questions and answers

### What is the share price of Indokem today?

Indokem (NSE: INDOKEM) last closed at ₹673.85 on 22 Oct 2026. Its 52-week high is ₹770.95 and its 52-week low is ₹555.00.

### What is the market cap of Indokem?

Indokem's market capitalisation is ₹1,879 Cr (₹1,879 Cr) at the 22 Oct 2026 close, ranking 1169th among the NSE companies Pivot tracks.

### What is the ROE and ROCE of Indokem?

Return on equity was 2.9% in FY26 and return on capital employed was 5.6% in FY26 (consolidated figures).

### Is Indokem a debt-free company?

No. Indokem's debt-to-equity ratio was 0.42 in FY26, with total debt of ₹25 Cr.

### What were Indokem's latest quarterly results?

For Q1 FY27 (quarter ended 30 Jun 2026), Indokem reported revenue of ₹47 Cr, +12.2% year on year, and net profit of ₹1 Cr, +52.9% year on year.

### What is the shareholding pattern of Indokem?

As of 30 Jun 2026: promoters 68.67%, domestic institutions 0.19%, non-institutions 31.14%.

### Who are Indokem's competitors?

The listed Chemicals companies closest to Indokem by market cap are India Glycols, Oriental Aromatics, Bodal Chemicals, S H Kelkar and Company, IG Petrochemicals and GOCL Corporation.

### Is Indokem a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Indokem's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on INDOKEM against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.